1354652-99-5 Usage
General Description
3-(methyl(2-morpholinoethyl)carbamoyl)benzoic acid is a chemical compound with the molecular formula C16H22N2O5. It is a derivative of benzoic acid with a carbamoyl group attached to the third carbon and a morpholinoethyl group attached to the methyl group. 3-(methyl(2-morpholinoethyl)carbamoyl)benzoic acid is used in pharmaceutical research as a potential drug candidate for the treatment of various diseases. It exhibits anti-inflammatory and analgesic properties and has shown potential in preclinical studies for the treatment of pain and inflammation. Additionally, it has also been investigated for its potential as an anticancer agent and has shown promising results in inhibiting the growth of cancer cells. Further research is ongoing to explore its therapeutic potential in various medical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1354652-99-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,4,6,5 and 2 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1354652-99:
(9*1)+(8*3)+(7*5)+(6*4)+(5*6)+(4*5)+(3*2)+(2*9)+(1*9)=175
175 % 10 = 5
So 1354652-99-5 is a valid CAS Registry Number.
1354652-99-5Relevant articles and documents
Compounds and methods for inhibiting phosphate transport
-
Page/Page column 234; 235, (2016/05/02)
Compounds having activity as phosphate transport inhibitors, more specifically, inhibitors of intestinal apical membrane Na/phosphate co-transport, are disclosed. The compounds have the following structure (I): including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein X, Y, A, R1 and R2 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT
-
Page/Page column 46-47, (2012/02/01)
Compounds having activity as phosphate transport inhibitors, more specifically, inhibitors of intestinal apical membrane Na/phosphate co-transport, are disclosed. The compounds have the following structure (I): including stereoisomers, pharmaceutically ac
